Phathom Pharmaceuticals (NASDAQ:PHAT) just reported results for the first quarter of 2024.
- Phathom Pharmaceuticals reported earnings per share of -$1.42. This was below the analyst estimate for EPS of -$1.24.
- The company reported revenue of $1.91 million.
- This was 6.73% worse than the analyst estimate for revenue of $2.05 million.